Erie County v. Eli Lilly and Company et al.

Why this Matters:

Plaintiff alleges that the actions of certain drug manufacturers and pharmacy benefit managers increase the cost of diabetes drugs in violation of the Racketeer Influenced and Corrupt Organizations Act, New York General Business Laws, and New York common law. The spillover effects from actions that boost the prices of prescription drugs can lead to states and localities being overcharged millions of dollars.

Potential Impact:

Additional tools to hold drug manufacturers and pharmacy benefit managers accountable for conduct that increases the prices of prescription drugs could allow health plans to reduce out of pocket costs for their enrollees.